The therapeutic potential of galanin in the management of pain - a review article.


Journal

Danish medical journal
ISSN: 2245-1919
Titre abrégé: Dan Med J
Pays: Denmark
ID NLM: 101576205

Informations de publication

Date de publication:
23 Jan 2024
Historique:
medline: 5 2 2024
pubmed: 5 2 2024
entrez: 5 2 2024
Statut: epublish

Résumé

Neuropeptides represent the most diverse family of neurotransmitters counting numerous members and even more G protein-coupled receptors, all of which are potential targets for drug development. Here, we focus on galanin and its three receptors by describing their possible involvement in pain and regeneration. Although animal experiments indicate that galanin, together with other molecules, may act as an endogenous system protecting against pain and improving nerve growth, these results have so far not been translated into patient treatments.

Identifiants

pubmed: 38314733
pii: A10230653
doi: 10.61409/A10230653
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

Auteurs

Tomas Hökfelt (T)

Department of Neuroscience, Biomedicum, Karolinska Institutet, Stockholm.

Zsuzsanna Wiesenfeld-Hallin (Z)

Department of Physiology and Pharmacology, Biomedicum, Karolinska Institutet, Stockholm, Sweden.

Classifications MeSH